WorkBoat Header Background Image

WorkBoat+ Membership – Free to Join

Download the WorkBoat Show App! Plan your schedule, explore exhibitors, and access event details anytime. Get the app › Click Here

Workboat Indexes

Recent Quotes
My Watchlist
Indicators
Local Stocks
Markets
Workboat Indexes
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cytosorbents Corporation - Common Stock (NQ:CTSO)

0.7104 -0.0346 (-4.64%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 6, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cytosorbents Corporation - Common Stock

< Previous 1 2 3 4 5 6 Next >
CytoSorbents Granted Expanded ANVISA Registration to Treat Shock with CytoSorb in Brazil
Advances CytoSorb as a Potentially Revolutionary Therapeutic Advance to Reverse Deadly Shock in Critically Ill and Cardiac Surgery Patients 
From CytoSorbents
Via GlobeNewswire
CytoSorbents Reports Second Quarter 2023 Financial and Operational Results
From CytoSorbents
Via GlobeNewswire
CytoSorbents to Report Second Quarter 2023 Operating and Financial Results
From CytoSorbents
Via GlobeNewswire
A Preview Of CytoSorbents's Earnings
 
Via Benzinga
Looking Into CytoSorbents's Return On Capital Employed
 
Via Benzinga
CytoSorbents Earnings Preview
 
Via Benzinga
CytoSorbents's Return On Capital Employed Overview
 
Via Benzinga
CytoSorbents Appoints Alexander D’Amico as Chief Financial Officer
From CytoSorbents
Via GlobeNewswire
CytoSorbents And Humedics Announce Theranostic Collaboration in the Field of Liver Disease
From CytoSorbents
Via GlobeNewswire
CytoSorbents Completes Enrollment of the STAR-T Pivotal Trial
From CytoSorbents
Via GlobeNewswire
CytoSorbents This Week to Host its Virtual Annual Stockholders Meeting and to Present at the Jefferies Healthcare Conference
From CytoSorbents
Via GlobeNewswire
CytoSorbents Reports First Quarter 2023 Results
Pivotal U.S. and Canada STAR-T Trial enrollment enters the last third of the study. Strong customer demand from Q4 2022 continued into Q1 2023, with current expectation of overall sales growth in 2023 
From CytoSorbents
Via GlobeNewswire
CytoSorbents to Report First Quarter 2023 Operating and Financial Results
From CytoSorbents
Via GlobeNewswire
CytoSorbents’ Pivotal STAR-T Trial Reaches Second Key Milestone With 80 Patients Enrolled
From CytoSorbents
Via GlobeNewswire
CytoSorbents Announces Board Chairman Al W. Kraus To Retire
From CytoSorbents
Via GlobeNewswire
Landmark Publication Underscores Robust Ability of CytoSorb to Reduce Cytokine Storm during Systemic Hyperinflammation
From CytoSorbents
Via GlobeNewswire
CytoSorbents Highlights New Clinical Data from Current Studies at the Live 42nd International Symposium on Intensive Care & Emergency Medicine (ISICEM)
From CytoSorbents
Via GlobeNewswire
CytoSorbents Comments on Bank Exposure and Diversified Cash Position
From CytoSorbents
Via GlobeNewswire
CytoSorbents Reports Fourth Quarter and Full Year 2022 Results
From CytoSorbents
Via GlobeNewswire
New European “Guidelines for the Management of Severe Perioperative Bleeding” Consider Hemoadsorption for the First-Time
From CytoSorbents
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
 
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
 
Via Benzinga
Why Cytosorbents Shares Are Popping Off Thursday
Cytosorbents Corp (NASDAQ: CTSO) shares are trading higher by 15.55% to $1.38 Thursday afternoon after the company announced it received $5 million in non-dilutive debt financing from Bridge Bank and... 
Via Benzinga
Why Yelp Shares Are Trading Lower By 15%? Here Are 86 Stocks Moving In Friday's Mid-Day Session
Gainers 
Via Benzinga
Why MediaAlpha Shares Jumped Around 30%; Here Are 112 Biggest Movers From Friday
Gainers 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Incannex Healthcare (NASDAQ:IXHL) shares moved upwards by 30.7% to $5.19 during Friday's pre-market session. The market value of their outstanding shares is at $316.2 million. 
Via Benzinga
Why Starbucks Shares Are Trading Higher; Here Are 43 Stocks Moving Premarket
Gainers Sentage Holdings Inc. (NASDAQ: SNTG) shares rose 67.7% to $5.10 in pre-market trading after jumping 24% on Thursday. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
We're starting off the final day of trading this week with a look at the biggest pre-market stock movers for Friday morning! 
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Monopar Therapeutics (NASDAQ:MNPR) shares increased by 53.0% to $4.09 during Wednesday's pre-market session. The company's market cap stands at $52.0 million. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
It's time for another look at the biggest pre-market stock movers as we check out what's happening with shares on Tuesday morning! 
Via InvestorPlace
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Privacy Policy DSAR Requests Terms of Use Locations Events, Products & Services
© 2025 Diversified Communications. All rights reserved.